FDA Warning Letter — Xo Biologix

Case 697717 — FEI 3015521757

The FDA took a Warning Letter action against Xo Biologix on December 13, 2024 (Austin, TX). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Xo Biologix
Date
December 13, 2024
Fiscal Year
2025
Product Type
Biologics
Center
CBER
Location
Austin, TX (United States)